Esa denied for missing prior authorization by Humana?

Humana's specific coverage criteria for esa are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for ESAs

ESAs carry a significant cost and, under FDA labeling, carry important safety considerations that Humana uses to justify mandatory prior authorization before the drug is dispensed or administered. The prior-authorization (PA) process requires the prescriber to submit clinical information — diagnosis, lab results, prior therapy — that Humana's clinical reviewers will compare against the plan's coverage criteria. A denial at the PA stage almost always means the submitted documentation was incomplete, the wrong form was used, or the clinical information as presented did not clearly satisfy the policy criteria.

## Why This Denial Is Appealable

A PA denial is a coverage determination and carries full appeal rights under both ERISA and the ACA. Because PA denials are often the result of documentation gaps rather than a genuine absence of medical necessity, a well-organized appeal that directly maps the clinical record to each policy criterion has a strong chance of success. The prescriber's involvement is critical.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA §2719): File within the deadline shown in the denial notice (often 60–180 days, depending on the plan). Request a peer-to-peer review with the Humana medical director as an early step — this can resolve many PA denials without a formal appeal.
• External review (ACA §2719): Available after a final internal denial. An Independent Review Organization will conduct an independent clinical assessment. File within approximately four months of the final denial.
• Expedited PA and appeal: If the condition is urgent, request an expedited PA decision (typically 72 hours) and invoke expedited appeal rights if it is denied.

## Concrete Appeal Steps

1. Obtain the specific denial reason code and the exact policy criteria cited in the denial letter. 2. Pull Humana's current ESA prior-authorization criteria from the provider portal. 3. The prescriber should request a peer-to-peer call with the Humana medical director before or alongside the formal appeal. 4. Compile the documentation package (below) and submit the internal appeal. 5. If denied again, escalate to IRO external review.

## Documentation to Gather

• Diagnosis confirmation: Chart notes, relevant ICD codes, and supporting diagnostics that establish the qualifying condition.
• Serial laboratory results: Printouts showing the hemoglobin/hematocrit trend over time — attach the actual lab reports rather than transcribing numbers.
• Prior therapy documentation: Records of any prior anemia management (iron, transfusions, dose adjustments of nephrotoxic medications) with dates and outcomes.
• Clinical severity assessment: Physician notes describing functional impact, transfusion burden, or quality-of-life impairment.
• Prescriber medical-necessity letter: Should map every PA criterion — from the FDA label and from Humana's PA policy — to a specific chart finding.

## Criteria-Mapping Structure

Download Humana's ESA prior-authorization form and policy. In your appeal letter, reproduce each criterion in the left column of a table. In the right column, cite the chart entry (date, note type, value) that satisfies it. Criteria you cannot satisfy should be addressed directly, not omitted.